Investing

AVROBIO Inc : AVRO

AVRO

Stock Data

$0.00

$0.00 (0.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases after a single dose worldwide. The company is headquartered in Cambridge, Massachusetts.

All AVRO Articles

3 Articles

Chris Lange | Jun 15, 2021 at 9:11 AM EDT

Tuesday Analyst Upgrades and Downgrades: Campbell Soup, Exact Sciences, Exelixis, Spirit Airlines, Sarepta, ZTO and More

Tuesday’s top analyst upgrades and downgrades included Campbell Soup, Exact Sciences, Exelixis, Pool, Spirit Airlines and ZTO Express.

Lee Jackson | May 27, 2021 at 8:51 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: Airbnb, CrowdStrike, DoorDash, Ford, Fortinet, Intuit, T-Mobile, Twilio, Zscaler and More

Thursday's top analyst upgrades and downgrades included Airbnb, CrowdStrike, DoorDash, Ford, Intuit, Lumber Liquidators, Occidental Petroleum, T-Mobile, Twilio, Uber and…

Jon C. Ogg | Aug 7, 2020 at 9:11 AM EDT

Top Analyst Upgrades and Downgrades: Alteryx, Booking, CarGurus, Datadog, FedEx, First Solar, Uber, Vonage, Yeti, Zillow and More

Friday's top analyst upgrades and downgrades included Alteryx, Booking, CarGurus, Datadog, FedEx, First Solar, Uber Technologies, Vonage, Yeti and Zillow.